SCHEMBL22765053

SCHEMBL22765053

O=S(=O)(Nc1cccc2ccc(CN(Cc3ccccn3)Cc3ccccn3)nc12)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 12/20 0.64
▸ GLO1 Q04760 5/20 0.50
▸ TDP1 Q9NUW8 5/20 0.47
▸ AGTR1 P30556 3/20 0.47
▸ NFKBIA P25963 2/20 0.47
▸ PAX8 Q06710 2/20 0.47
▸ G6PD P11413 1/20 0.47
▸ METAP2 P50579 1/20 0.47
▸ METAP1 P53582 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ KMT2A Q03164 5/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ LMNA P02545 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HTT P42858 2/20 0.45
▸ MITF O75030 1/20 0.45
▸ S1PR4 O95977 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ S1PR1 P21453 1/20 0.45
▸ OPRK1 P41145 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30471527 1.00 SLC40A1 (0.64) SLC40A1GLO1TDP1AGTR1NFKBIA
SCHEMBL22765090 0.87 SLC40A1 (0.65) SLC40A1GLO1TDP1AGTR1NFKBIA
SCHEMBL26053674 0.87 SLC40A1 (0.61) SLC40A1GLO1TDP1AGTR1NFKBIA
SCHEMBL22764963 0.86 SLC40A1 (0.59) SLC40A1GLO1TDP1AGTR1NFKBIA
SCHEMBL22765211 0.85 SLC40A1 (0.63) SLC40A1GLO1TDP1AGTR1NFKBIA
SCHEMBL30471541 0.85 SLC40A1 (0.64) SLC40A1GLO1TDP1AGTR1NFKBIA
SCHEMBL22765115 0.85 SLC40A1 (0.64) SLC40A1GLO1TDP1AGTR1NFKBIA
SCHEMBL22764831 0.84 SLC40A1 (0.57) SLC40A1GLO1TDP1AGTR1NFKBIA
SCHEMBL22765054 0.84 SLC40A1 (0.57) SLC40A1GLO1TDP1AGTR1NFKBIA
SCHEMBL22765055 0.84 SLC40A1 (0.60) SLC40A1GLO1TDP1AGTR1NFKBIA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691949-B2 Quinoline sulfonamide compounds and their use as antibacterial agents OTAGO INNOVATION LIMITED (NZ) 2023-07-04 — — US disclosed
US-20200385354-A1 Quinoline Sulfonamide Compounds and Their Use as Antibacterial Agents OTAGO INNOVATION LIMITED (NZ) 2020-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691949-B2 Quinoline sulfonamide compounds and their use as antibacterial agents NQO2, SDHA, SIRT5 SLC40A1 4081/4885GLO1 369/4885TDP1 4605/4885
US-20200385354-A1 Quinoline Sulfonamide Compounds and Their Use as Antibacterial Agents NQO2, SDHA, SIRT5 SLC40A1 4081/4885GLO1 369/4885TDP1 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback